Variant report

Variant	nsv1063224
Chromosome Location	chr19:41338835-41370781
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:375)
CpG islands
(count:305)
Chromatin interactive
region (count:4)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:375 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:41370633-41370945	K562	blood:	n/a	n/a
2	ATF1	chr19:41339642-41339915	K562	blood:	n/a	n/a
3	ATF1	chr19:41370536-41370948	K562	blood:	n/a	n/a
4	ATF3	chr19:41339727-41339986	K562	blood:	n/a	n/a
5	ATF3	chr19:41339265-41339474	K562	blood:	n/a	n/a
6	ATF3	chr19:41370620-41370877	K562	blood:	n/a	n/a
7	BHLHE40	chr19:41339267-41339464	K562	blood:	n/a	n/a
8	BHLHE40	chr19:41339813-41339844	K562	blood:	n/a	n/a
9	CBX3	chr19:41370123-41371107	K562	blood:	n/a	n/a
10	CBX3	chr19:41339143-41339980	K562	blood:	n/a	n/a
11	CBX3	chr19:41347915-41348277	K562	blood:	n/a	n/a
12	CBX3	chr19:41349182-41350047	K562	blood:	n/a	n/a
13	CBX3	chr19:41347938-41348304	K562	blood:	n/a	n/a
14	CCNT2	chr19:41339675-41339875	K562	blood:	n/a	n/a
15	CCNT2	chr19:41370582-41370786	K562	blood:	n/a	n/a
16	CEBPB	chr19:41343058-41343265	A549	lung:	n/a	chr19:41343121-41343132
17	CEBPB	chr19:41370305-41370801	K562	blood:	n/a	chr19:41370433-41370441
18	CEBPB	chr19:41343053-41343247	H1-hESC	embryonic stem cell:	n/a	chr19:41343121-41343132
19	CEBPB	chr19:41343011-41343287	HepG2	liver:	n/a	chr19:41343121-41343132
20	CEBPB	chr19:41343006-41343268	IMR90	lung:	n/a	chr19:41343121-41343132
21	CEBPB	chr19:41342862-41343338	A549	lung:	n/a	chr19:41343121-41343132
22	CEBPB	chr19:41362024-41362201	K562	blood:	n/a	n/a
23	CEBPB	chr19:41370209-41371189	K562	blood:	n/a	chr19:41370433-41370441
24	CEBPB	chr19:41339359-41340046	K562	blood:	n/a	chr19:41339540-41339548
25	CEBPB	chr19:41370543-41370910	K562	blood:	n/a	n/a
26	CEBPB	chr19:41339552-41339909	K562	blood:	n/a	n/a
27	CEBPB	chr19:41368416-41368601	K562	blood:	n/a	n/a
28	CEBPB	chr19:41342957-41343295	K562	blood:	n/a	chr19:41343121-41343132
29	CEBPB	chr19:41368480-41368982	A549	lung:	n/a	n/a
30	CEBPB	chr19:41368761-41369068	Hela-S3	cervix:	n/a	n/a
31	CEBPB	chr19:41339647-41339931	K562	blood:	n/a	n/a
32	CEBPB	chr19:41367289-41367476	A549	lung:	n/a	n/a
33	CEBPD	chr19:41370295-41371143	K562	blood:	n/a	n/a
34	CEBPD	chr19:41339436-41340105	K562	blood:	n/a	n/a
35	CEBPD	chr19:41370661-41370862	K562	blood:	n/a	n/a
36	CTCF	chr19:41354333-41354798	H1-hESC	embryonic stem cell:	n/a	chr19:41354699-41354709
37	CTCF	chr19:41349663-41349752	Spleen_OC	spleen:	n/a	n/a
38	CTCF	chr19:41354540-41354690	HCM	heart:	n/a	n/a
39	CTCF	chr19:41368500-41368650	NHLF	lung:	n/a	n/a
40	CTCF	chr19:41368320-41368470	AG09309	skin:	n/a	n/a
41	CTCF	chr19:41354359-41354806	A549	lung:	n/a	chr19:41354699-41354709
42	CTCF	chr19:41354459-41354759	K562	blood:	n/a	chr19:41354699-41354709
43	CTCF	chr19:41354322-41355358	A549	lung:	n/a	chr19:41355271-41355289 chr19:41354699-41354709
44	CTCF	chr19:41354312-41354785	K562	blood:	n/a	chr19:41354699-41354709
45	CTCF	chr19:41367440-41367590	K562	blood:	n/a	n/a
46	CTCF	chr19:41364222-41364240	Hela-S3	cervix:	n/a	n/a
47	CTCF	chr19:41354500-41354650	BJ	skin:	n/a	n/a
48	CTCF	chr19:41360494-41360547	Kidney_OC	kidney:	n/a	n/a
49	CTCF	chr19:41364072-41364366	K562	blood:	n/a	n/a
50	CTCF	chr19:41354460-41354610	AG10803	skin:	n/a	n/a

(count:305 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:41354682-41354732	HCT-116	colon:	n/a
2	chr19:41351924-41351974	AG04450	lung:	fetal
3	chr19:41354553-41354603	NH-A	brain:	n/a
4	chr19:41354142-41354192	HCF	heart:	n/a
5	chr19:41351924-41351974	AG10803	skin:	n/a
6	chr19:41351924-41351974	AG09319	gingival:	n/a
7	chr19:41351924-41351974	HAEpiC	amniotic membrane:	n/a
8	chr19:41355973-41356023	ProgFib	skin:	n/a
9	chr19:41351924-41351974	Caco-2	colon:	n/a
10	chr19:41351924-41351974	GM19239	blood:	n/a
11	chr19:41354553-41354603	HEK293	kidney:	embryo
12	chr19:41354142-41354192	PrEC	prostate:	n/a
13	chr19:41354553-41354603	AG10803	skin:	n/a
14	chr19:41354142-41354192	HCT-116	colon:	n/a
15	chr19:41354553-41354603	T-47D	breast:	n/a
16	chr19:41354682-41354732	PANC-1	pancreas:	n/a
17	chr19:41354142-41354192	NHDF-neo	bronchial:	n/a
18	chr19:41355973-41356023	A549	lung:	n/a
19	chr19:41355973-41356023	IMR90	lung:	fetal
20	chr19:41354553-41354603	GM12878	blood:	n/a
21	chr19:41355973-41356023	SKMC	muscle:	n/a
22	chr19:41354553-41354603	HCT-116	colon:	n/a
23	chr19:41354682-41354732	SK-N-SH	brain:	n/a
24	chr19:41354142-41354192	ProgFib	skin:	n/a
25	chr19:41354553-41354603	SK-N-SH_RA	brain:	n/a
26	chr19:41354142-41354192	PFSK-1	brain:	n/a
27	chr19:41354553-41354603	PrEC	prostate:	n/a
28	chr19:41354553-41354603	HRE	kidney:	n/a
29	chr19:41351924-41351974	MCF-7	breast:	n/a
30	chr19:41354553-41354603	Jurkat	blood:	n/a
31	chr19:41354553-41354603	BE2_C	brain:	n/a
32	chr19:41354682-41354732	NB4	blood:	n/a
33	chr19:41354553-41354603	PFSK-1	brain:	n/a
34	chr19:41355973-41356023	K562	blood:	n/a
35	chr19:41354142-41354192	MCF-7	breast:	n/a
36	chr19:41354142-41354192	HRE	kidney:	n/a
37	chr19:41354553-41354603	HUVEC	blood vessel:	n/a
38	chr19:41355973-41356023	H1-hESC	embryonic stem cell:	embryo
39	chr19:41355973-41356023	HCF	heart:	n/a
40	chr19:41355973-41356023	Jurkat	blood:	n/a
41	chr19:41355973-41356023	HPAEpiC	pulmonary alveolar:	n/a
42	chr19:41354553-41354603	U87	brain:	n/a
43	chr19:41354142-41354192	SAEC	small airway:	n/a
44	chr19:41355973-41356023	NH-A	brain:	n/a
45	chr19:41355973-41356023	HRPEpiC	eye:	n/a
46	chr19:41354553-41354603	AG04450	lung:	fetal
47	chr19:41351924-41351974	HL-60	blood:	n/a
48	chr19:41351924-41351974	NB4	blood:	n/a
49	chr19:41354553-41354603	GM12891	blood:	n/a
50	chr19:41355973-41356023	HRCEpiC	kidney:	n/a

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:41195484..41197379-chr19:41368669..41371255,2	K562	blood:
2	chr19:41369230..41371017-chr19:41372027..41374078,2	K562	blood:
3	chr19:41168873..41171001-chr19:41337568..41339858,2	MCF-7	breast:
4	chr16:4474827..4477394-chr19:41351022..41353007,2	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CYP2A6-1	chr19:41342991-41343115	ENSG00000269843.1

No data

Variant related genes	Relation type
ENSG00000269843	TF binding region
CYP2A6	TF binding region
ENSG00000269843	CpG island
CYP2A6	CpG island
ENSG00000105245	chromatin interactions
ENSG00000262246	chromatin interactions
ENSG00000103423	chromatin interactions

Extended variants
information (count: 1569 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:1569 , 50 per page) page: 1 2 3 4 5 6 7 ... 32

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2258314	chr19:41338835-41338836	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs143200968	chr19:41338847-41338848	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs2258380	chr19:41338988-41338989	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs543459052	chr19:41339052-41339053	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs546635566	chr19:41339142-41339143	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs374582198	chr19:41339146-41339147	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs564847297	chr19:41339202-41339203	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs577238776	chr19:41339205-41339206	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs148279271	chr19:41339220-41339221	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs559545069	chr19:41339230-41339231	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs539155316	chr19:41339237-41339238	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs55716646	chr19:41339238-41339239	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs548323056	chr19:41339252-41339253	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs561060287	chr19:41339280-41339281	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs531663951	chr19:41339281-41339282	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs549790238	chr19:41339290-41339291	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs571288425	chr19:41339303-41339304	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs538984876	chr19:41339371-41339372	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs137979373	chr19:41339379-41339380	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs398041008	chr19:41339423-41339424	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs34297200	chr19:41339435-41339436	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs547773621	chr19:41339440-41339441	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs114811084	chr19:41339444-41339445	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs370261473	chr19:41339450-41339451	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs536456630	chr19:41339452-41339453	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs555113391	chr19:41339455-41339456	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs192279832	chr19:41339461-41339462	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs183183221	chr19:41339463-41339464	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs558620180	chr19:41339509-41339510	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs576899459	chr19:41339529-41339530	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs540974272	chr19:41339565-41339566	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs559396852	chr19:41339566-41339567	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs12981985	chr19:41339603-41339604	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	mRNA abundance
34	rs541679459	chr19:41339617-41339618	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs563119272	chr19:41339630-41339631	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs62108998	chr19:41339669-41339670	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs531722553	chr19:41339704-41339705	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs59369253	chr19:41339740-41339741	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs549851814	chr19:41339792-41339793	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs564982944	chr19:41339795-41339796	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs576204779	chr19:41339796-41339797	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs536800503	chr19:41339834-41339835	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs7247231	chr19:41339837-41339838	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs7246188	chr19:41339842-41339843	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs541332546	chr19:41339855-41339856	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs186037008	chr19:41339871-41339872	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs12459249	chr19:41339896-41339897	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
48	rs548827996	chr19:41339913-41339914	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs145934699	chr19:41339936-41339937	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs190365632	chr19:41339977-41339978	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:380 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:41324800-41339200	Weak transcription	Brain Germinal Matrix	brain
2	chr19:41326000-41339800	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
3	chr19:41330000-41339800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
4	chr19:41330200-41349400	Weak transcription	Right Ventricle	heart
5	chr19:41331600-41339800	Weak transcription	Fetal Lung	lung
6	chr19:41333400-41339200	Weak transcription	Brain Angular Gyrus	brain
7	chr19:41333400-41339200	Weak transcription	Brain Substantia Nigra	brain
8	chr19:41333600-41339000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
9	chr19:41333600-41339200	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
10	chr19:41333600-41339800	Weak transcription	Brain Inferior Temporal Lobe	brain
11	chr19:41333600-41349400	Weak transcription	Left Ventricle	heart
12	chr19:41333800-41339200	Weak transcription	Primary T helper cells fromperipheralblood	blood
13	chr19:41334000-41339200	Weak transcription	Primary T helper naive cells from peripheral blood	blood
14	chr19:41334000-41339200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
15	chr19:41334000-41339200	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
16	chr19:41334000-41339200	Weak transcription	Primary T killer memory cells from peripheral blood	blood
17	chr19:41334000-41339800	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
18	chr19:41334200-41339000	Weak transcription	Primary T cells fromperipheralblood	blood
19	chr19:41334200-41339200	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
20	chr19:41334200-41339200	Weak transcription	Primary T helper cells PMA-I stimulated	--
21	chr19:41336200-41339000	Weak transcription	Breast Myoepithelial Primary Cells	Breast
22	chr19:41336400-41340200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
23	chr19:41336400-41340800	Enhancers	Fetal Intestine Large	intestine
24	chr19:41336600-41339400	Enhancers	Ovary	ovary
25	chr19:41336600-41340800	Enhancers	Fetal Intestine Small	intestine
26	chr19:41337000-41339600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
27	chr19:41337200-41339000	Enhancers	NHDF-Ad	bronchial
28	chr19:41337200-41339600	Enhancers	Rectal Mucosa Donor 29	rectum
29	chr19:41337200-41340000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
30	chr19:41337200-41340000	Enhancers	Adipose Nuclei	Adipose
31	chr19:41337200-41340000	Enhancers	Liver	Liver
32	chr19:41337200-41340000	Enhancers	Osteobl	bone
33	chr19:41337200-41340200	Enhancers	Placenta	Placenta
34	chr19:41337400-41339200	Enhancers	K562	blood
35	chr19:41337400-41339400	Enhancers	Rectal Mucosa Donor 31	rectum
36	chr19:41337400-41340200	Enhancers	Primary monocytes fromperipheralblood	blood
37	chr19:41337400-41340200	Enhancers	Primary hematopoietic stem cells short term culture	blood
38	chr19:41337400-41340200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
39	chr19:41337600-41340000	Enhancers	Monocytes-CD14+_RO01746	blood
40	chr19:41338400-41339600	Enhancers	Primary T cells from cord blood	blood
41	chr19:41338600-41339000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
42	chr19:41338600-41339000	Weak transcription	Pancreas	Pancrea
43	chr19:41338600-41339200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
44	chr19:41338600-41339200	Weak transcription	Rectal Smooth Muscle	rectum
45	chr19:41338600-41339200	Weak transcription	HSMMtube	muscle
46	chr19:41338600-41339400	Enhancers	Skeletal Muscle Female	skeletal muscle
47	chr19:41338600-41344000	Weak transcription	A549	lung
48	chr19:41338800-41339800	Weak transcription	HepG2	liver
49	chr19:41338800-41341000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
50	chr19:41339000-41339200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links